Since IL-13 was associated with an adverse lipid profile, its inverse relationship with augmentation index suggests that its cardiovascular effects may be at least partially independent of circulating lipids.
Abstract
Systemic lupus erythematosus (SLE) is characterized by elevated levels of various cytokines. Interleukin (IL)-13 is a pleiotropic type 2 cytokine that plays a central role in allergic inflammation and tissue fibrosis. Until recently, serum measurement of IL-13 was not feasible because of its extremely low concentration. New highly sensitive techniques now allow its quantification at the femtogram level. In the present study, we aimed to evaluate the association between SLE-disease characteristics and ultrasensitive serum IL-13 levels. In this cross-sectional study, a comprehensive characterization of 313 patients with SLE was performed, including autoantibody profiles and indices of disease activity (SLE-DAS, SLEDAI-2 K, and LLDAS), damage (SLICC-DI), and remission (DORIS). In addition, the cohort was evaluated with complete hematological and lipid profiles, insulin resistance indices, and assessment of subclinical carotid atherosclerosis and carotid stiffness. Serum IL-13 levels were measured using the Simoa (Single Molecule Array) technique. Multivariable linear regression analyses were then conducted to examine the associations between these disease characteristics and circulating IL-13. In multivariable regression analyses demographic features, disease activity indices (SLEDAI-2 K, SLE-DAS, DORIS), damage scores, overall disease duration, autoantibodies and interferon or complement levels were not associated with IL-13. However, in the adjusted models, neutrophil and platelet counts showed an inverse association with IL-13. It was also the case for metabolic factors, as higher levels of HDL-cholesterol and apolipoprotein A1 were independently associated with lower IL-13 levels, while a higher LDL: HDL ratio, a higher ApoB: ApoA1 ratio, and a higher atherogenic index were associated with superior IL-13 levels. In contrast, augmentation index was inversely and independently associated with IL-13. Serum IL-13 levels are not associated with key SLE-related features such as disease activity or the autoantibodies profile. Since IL-13 was associated with an adverse lipid profile, its inverse relationship with augmentation index suggests that its cardiovascular effects may be at least partially independent of circulating lipids. These apparently divergent associations likely reflect distinct but interconnected pathways through which IL-13 influences cardiovascular risk in SLE.
OBJECTIVES
Hematological abnormalities are common in systemic lupus erythematosus (SLE). Interferon-α (IFN-α) and interferon-γ (IFN-γ) play pivotal roles in the immunopathogenesis of SLE. However, their measurement in serum has long been limited by their extremely low circulating concentrations. With the advent of ultr...
Marta Rodríguez-García, F. Gómez-Bernal, J. C. Quevedo-Abeledo et al.· Rheumatology· 0 citations
Hypertension (HTN) is the leading modifiable risk factor of cardiovascular diseases. Implicated immunological mechanisms are of great interest nowadays. This study aimed to assess the role of B cells by measuring serum immunoglobulin (IgG) and IgM levels, regulatory T cell levels, and interleukin (IL)-10 levels in hype...
Zainab A. Ashour, M. A. Y. Aldeeb, H. E. Abdelwahab et al.· Egyptian Journal of Immunolo...· 0 citations
It is found that serum IL-12 levels were associated with interferon-γ levels and rheumatoid factor positivity in patients with RA, supporting a role for IL-12 at the interface between cellular and humoral immunity.
I. Ferraz-Amaro, J. C. Quevedo-Abeledo, Enrique García-Barrera et al.· Diagnostics· 0 citations
Objective To evaluate the utility of novel parameters related to immune cell activation, known as white blood cell parameters of inflammation (WBC‐IP), as biomarkers of disease activity in childhood‐onset systemic lupus erythematosus (cSLE) and compare their performance with conventional markers, including erythrocyte...
Butsabong Lerkvaleekul, N. Sirachainan, Duantida Songdej et al.· ACR Open Rheumatology· 0 citations
Background: Vitiligo is a chronic immune-mediated depigmenting disorder accompanied by both hyperactive inflammatory and autoimmunity pathways. Objective: To evaluate the serum levels of interleukin-6 (IL-6), interleukin-17 (IL-17), and tumor necrosis factor-A (TNF-A) in vitiligo patients, determine the correlation of...
Saleem Abbas Ajzan· Jana Nexus: Journal of Healt...· 0 citations
Background.
Systemic lupus erythematosus (SLE) is characterized by substantial clinical and immunological heterogeneity, which complicates the assessment of disease activity and monitoring of systemic inflammation. In recent years, increasing attention has been paid to systemic inflammation indices derived from comp...
A. D. Kiseleva, Y. Karpova· Russian Journal for Personal...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.